Raf Inhibitors Target Ras Spatiotemporal Dynamics

被引:49
|
作者
Cho, Kwang-jin [2 ]
Kasai, Rinshi S. [3 ]
Park, Jin-Hee [2 ]
Chigurupati, Sravanthi [2 ]
Heidorn, Sonja J. [1 ]
van der Hoeven, Dharini [2 ]
Plowman, Sarah J. [2 ]
Kusumi, Akihiro [3 ,4 ]
Marais, Richard [1 ]
Hancock, John F. [2 ]
机构
[1] Inst Canc Res, Sect Cell & Mol Biol, Signal Transduct Team, London SW3 6JB, England
[2] Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA
[3] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan
[4] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068507, Japan
关键词
K-RAS; NANOCLUSTER FORMATION; TUMOR PROGRESSION; LIPID RAFTS; H-RAS; ACTIVATION; BRAF; ERK; DEPENDENCE; PROTEINS;
D O I
10.1016/j.cub.2012.03.067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The lateral segregation of Ras proteins into transient plasma membrane nanoclusters is essential for high-fidelity signal transmission by the Ras mitogen-activated protein kinase (MAPK) cascade. In this spatially constrained signaling system, the dynamics of Ras nanocluster assembly and disassembly control MAPK signal output. Results: We show here that BRaf inhibitors paradoxically activate CRaf and MAPK signaling in Ras transformed cells by profoundly dysregulating Ras nanocluster dynamics. Specifically, BRaf inhibitors selectively enhance the plasma membrane nanoclustering of oncogenic K-Ras and N-Ras but have no effect on H-Ras nanoclustering. Raf inhibitors are known to drive the formation of stable BRaf-CRaf and CRaf-CRaf dimers. Our results demonstrate that the presence of two Ras-binding domains in a single Raf dimer is sufficient and required to increase Ras nanoclustering, indicating that Raf dimers promote K- and N-Ras nanocluster formation by crosslinking constituent Ras proteins. Ras crosslinking increases the fraction cif K-Ras and N-Ras in their cognate nanoclusters, leading to an increase in MAPK output from the plasma membrane. Intriguingly, increased MAPK signaling in BRaf inhibited cells is accompanied by significantly decreased Akt activation. We show that this signal pathway crosstalk results from a novel mechanism of competition between stabilized Raf dinners and p110 alpha for recruitment to Ras nanoclusters. Conclusions: Our findings reveal that BRaf inhibitors disrupt Ras nanocluster dynamics with significant, yet divergent, consequences for MAPK and PI3K signaling.
引用
收藏
页码:945 / 955
页数:11
相关论文
共 50 条
  • [31] Design, synthesis, and antitumor activity of stapled peptide inhibitors targeting the RAS-RAF interactions
    Han, Dan
    Yu, Zhou
    Zhang, Kai
    Gai, Conghao
    Zhang, Peichao
    Chai, Xiaoyun
    Zhuo, Xiaobing
    Zhao, Qingjie
    Zou, Yan
    Zhu, Lie
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 290
  • [32] Targeting M-Ras and Raf kinases by dual allosteric inhibitors Nicholas Nesh.
    Nesh, Nicholas
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 183A - 183A
  • [33] RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
    Oberholzer, Patrick A.
    Kee, Damien
    Dziunycz, Piotr
    Sucker, Antje
    Kamsukom, Nyam
    Jones, Robert
    Roden, Christine
    Chalk, Clinton J.
    Ardlie, Kristin
    Palescandolo, Emanuele
    Piris, Adriano
    MacConaill, Laura E.
    Robert, Caroline
    Hofbauer, Guenther F. L.
    McArthur, Grant A.
    Schadendorf, Dirk
    Garraway, Levi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) : 316 - 321
  • [34] Genotype-based combinations of RAS/RAF and PI3K pathway inhibitors
    Banerji, U.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S7 - S7
  • [35] Ras-Raf-MEK Pathway
    Schellens, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S14 - S15
  • [36] Ras, Raf, and MAP Kinase in Melanoma
    Solus, Jason F.
    Kraft, Stefan
    ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (04) : 217 - 226
  • [37] RAF/RAS mutations in ovarian neoplasms
    Macropoulos, P
    Sieben, N
    Kolkman-Uljee, SM
    Al Adani, M
    Roemen, MJM
    de Goeij, APM
    Fleuren, J
    Diss, T
    Hamoudi, R
    Warren, B
    Krausz, T
    Flanagan, AM
    JOURNAL OF PATHOLOGY, 2003, 201 : 11A - 11A
  • [38] Dual function of Ras in Raf activation
    Li, W
    Melnick, M
    Perrimon, N
    DEVELOPMENT, 1998, 125 (24): : 4999 - 5008
  • [39] A structural model of a Ras–Raf signalosome
    Venkatesh P. Mysore
    Zhi-Wei Zhou
    Chiara Ambrogio
    Lianbo Li
    Jonas N. Kapp
    Chunya Lu
    Qi Wang
    Maxwell R. Tucker
    Jeffrey J. Okoro
    Gabriela Nagy-Davidescu
    Xiaochen Bai
    Andreas Plückthun
    Pasi A. Jänne
    Kenneth D. Westover
    Yibing Shan
    David E. Shaw
    Nature Structural & Molecular Biology, 2021, 28 : 847 - 857
  • [40] Differential effects of dimerization on B-Raf and C-Raf function revealed by mutational analysis and peptide inhibitors that target the Raf dimer interface
    Freeman, Alyson K.
    Ritt, Daniel A.
    Morrison, Deborah K.
    CANCER RESEARCH, 2012, 72